Atlas Trials

Intas Pharmaceuticals, Ltd.

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Intas Pharmaceuticals, Ltd.

RecordFirmDate
Comparative Immunogenicity Study of Multiple Doses of Proposed Pegfilgrastim Biosimilar, INTP5 of Intas Pharmaceuticals Ltd., India Against Neulasta of Amgen Inc., USA in Healthy, Adult Human Subjects. (NCT04015232)Intas Pharmaceuticals, Ltd.2018-02-26
Comparative, Pharmacokinetic and Pharmacodynamic Study of Subcutaneous Injections of INTP5 of Intas Pharmaceuticals Ltd., India Against Neulasta of Amgen Inc., USA in Healthy, Adult Human Subjects. (NCT04014062)Intas Pharmaceuticals, Ltd.2018-02-12

Track Intas Pharmaceuticals, Ltd. automatically

Every clearance here is in the API, with alerts when new ones post.